A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Progabide
Aclidinium
The risk or severity of adverse effects can be increased when Quetiapine is combined with Aclidinium.
Progabide
Thalidomide
Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Progabide
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Progabide
Suvorexant
Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Progabide
Sodium oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Progabide
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Quetiapine.
Progabide
Rotigotine
Quetiapine may increase the sedative activities of Rotigotine.
Progabide
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Progabide
Paraldehyde
Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Progabide
Orphenadrine
Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Progabide
Methotrimeprazine
Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Progabide
Hydrocodone
Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Progabide
Levodopa
The risk or severity of hypotension and orthostatic hypotension can be increased when Quetiapine is combined with Levodopa.
Progabide
Ivabradine
Quetiapine may increase the QTc-prolonging activities of Ivabradine.
Brompheniramine
Satralizumab
The serum concentration of Budesonide can be decreased when it is combined with Satralizumab.
Brompheniramine
Oliceridine
The serum concentration of Oliceridine can be decreased when it is combined with Budesonide.
Brompheniramine
Abametapir
The serum concentration of Budesonide can be increased when it is combined with Abametapir.
Brompheniramine
Inebilizumab
The risk or severity of infection can be increased when Budesonide is combined with Inebilizumab.
Brompheniramine
Selpercatinib
The serum concentration of Selpercatinib can be decreased when it is combined with Budesonide.
Brompheniramine
Capmatinib
The serum concentration of Capmatinib can be decreased when it is combined with Budesonide.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3